Anniek van Hienen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anniek van Hienen has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andre Dekker
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
2 shared publications - Ekaterina Sergeevna Akhmad
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow, Russia
2 shared publications - Hannah Piehl
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht University, Paul Henri Spaaklaan 1, Maastricht, 6229 EN, The Netherlands, +31 (0)43 38 81863
2 shared publications - Johan van Soest
Brightlands Institute for Smart Society (BISS), Faculty of Science and Engineering, Maastricht University, The Netherlands
2 shared publications - Laura Hochstenbach
Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands
2 shared publications - Madeline Therrien
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht University, Paul Henri Spaaklaan 1, Maastricht, 6229 EN, The Netherlands, +31 (0)43 38 81863
2 shared publications
Latest Publications
- Open Access
- 12 March 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12 (1) , e85228
Understanding Clinicians’ Informational Needs for AI-Driven Clinical Decision Support Systems: Qualitative Interview Study
Background: Advancements in artificial intelligence (AI) are transforming health care, particularly through AI-driven clinical decision support systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. Objective: This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel, this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. Methods: A qualitative description design study was conducted using semistructured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards, including Model Cards, Model Facts, and the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis–Artificial Intelligence (TRIPOD-AI) checklist. The transcripts were analyzed through codebook thematic analysis. Results: Four key themes were identified: (1) clinicians need clear information on training data, its origin, size, and inclusion and exclusion criteria, to judge model applicability; (2) performance metrics must go beyond the area under the curve (AUC) and be clinically relevant to support informed decisions; (3) limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; and (4) information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon, and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the usability gap. Conclusions: To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- 12 March 2026
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 12 (1) , e85228
Open AccessUnderstanding Clinicians’ Informational Needs for AI-Driven Clinical Decision Support Systems: Qualitative Interview Study
Background: Advancements in artificial intelligence (AI) are transforming health care, particularly through AI-driven clinical decision support systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. Objective: This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel, this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. Methods: A qualitative description design study was conducted using semistructured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards, including Model Cards, Model Facts, and the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis–Artificial Intelligence (TRIPOD-AI) checklist. The transcripts were analyzed through codebook thematic analysis. Results: Four key themes were identified: (1) clinicians need clear information on training data, its origin, size, and inclusion and exclusion criteria, to judge model applicability; (2) performance metrics must go beyond the area under the curve (AUC) and be clinically relevant to support informed decisions; (3) limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; and (4) information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon, and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the usability gap. Conclusions: To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- Open Access
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Understanding Clinicians’ Informational Needs for AI-driven Clinical Decision Support Systems: Qualitative Interview Study (Preprint)
BACKGROUND Advancements in Artificial Intelligence (AI) are transforming healthcare, particularly through AI-driven Clinical Decision Support Systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. OBJECTIVE This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. METHODS A qualitative description design study was conducted using semi-structured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards including Model Cards (Mitchell et al., 2019), Model Facts (Sendak et al., 2020), and the TRIPOD-AI checklist (Collins et al., 2015, 2024). The transcripts were analyzed through codebook thematic analysis. RESULTS Four key themes were identified: (i) Clinicians need clear information on training data, its origin, size, and inclusion/exclusion criteria, to judge model applicability; (ii) Performance metrics must go beyond AUC and be clinically relevant to support informed decisions; (iii) Limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; (iv) Information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the current usability gap. CONCLUSIONS To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.
- 3 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnderstanding Clinicians’ Informational Needs for AI-driven Clinical Decision Support Systems: Qualitative Interview Study (Preprint)
BACKGROUND Advancements in Artificial Intelligence (AI) are transforming healthcare, particularly through AI-driven Clinical Decision Support Systems (AI-CDSS) that aid in predicting disease progression and personalizing treatment. Despite their potential, adoption remains limited due to clinician concerns about algorithm misuse, misinterpretation, and lack of transparency. OBJECTIVE This qualitative study explores the informational needs and preferences of clinicians to better understand and appropriately use AI-CDSS in decision-making. In parallel this study explores AI experts’ perspectives on what information should be communicated to enable safe and appropriate use of AI-CDSS. METHODS A qualitative description design study was conducted using semi-structured interviews with 16 participants (8 clinicians and 8 AI experts). Discussions focused on experiences with AI, informational needs, and feedback on existing reporting standards including Model Cards (Mitchell et al., 2019), Model Facts (Sendak et al., 2020), and the TRIPOD-AI checklist (Collins et al., 2015, 2024). The transcripts were analyzed through codebook thematic analysis. RESULTS Four key themes were identified: (i) Clinicians need clear information on training data, its origin, size, and inclusion/exclusion criteria, to judge model applicability; (ii) Performance metrics must go beyond AUC and be clinically relevant to support informed decisions; (iii) Limitations and warnings about inappropriate use should be specific and clearly communicated to prevent misuse; (iv) Information should be presented in layered, customizable formats within existing clinical software, avoiding unnecessary jargon and allowing optional deeper explanations. While each of the reviewed reporting standards offered strengths, none were considered sufficient alone. Participants recommended a combined and clinician-centered approach to information delivery. Alignment of reporting standards with clinical workflows and decision thresholds was thought to be crucial to bridge the current usability gap. CONCLUSIONS To improve AI-CDSS adoption in clinical practice, reporting standards must be designed for better clinician comprehension and usability. Enhancing transparency, particularly regarding training data and performance, can likely help clinicians assess AI-CDSS more effectively. Information should be delivered in an accessible, layered format, fitting clinical workflows. Co-creation with clinicians throughout AI-CDSS development was a cross-cutting theme, highlighting its importance in ensuring tools are not only technically sound but also practically usable. Future research should explore how to structurally report on performance and validation metrics for clinician understanding and assess the impact of information provision on AI-CDSS adoption.